Goldman warned 'curing patients isn't a sustainable business model' in 2018 — biotech is proving it right [Yahoo! Finance]
Goldman Sachs Group, Inc. (The) (GS)
Last goldman sachs group, inc. (the) earnings: 4/15 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
goldmansachs.com/investor-relations
Company Research
Source: Yahoo! Finance
It can theoretically cure debilitating or fatal conditions such as sickle cell anemia, spinal muscular atrophy and even different types of cancer. At first blush, gene therapy seems like it would be a very profitable area of research. For many of the conditions it targets, patients have few options to manage their illness, much less cure it. Must Read Thanks to Jeff Bezos, you can now become a landlord for as little as $100 — and no, you don't have to deal with tenants or fix freezers. Here's how Robert Kiyosaki says this 1 asset will surge 400% in a year and begs investors not to miss this ‘explosion' Dave Ramsey warns nearly 50% of Americans are making 1 big Social Security mistake — here's how to fix it ASAP But in 2018, Goldman Sachs released a report (2) predicting gene therapy could be a “challenge” for developers looking for “sustained cash flow.” It said that because gene therapy aims to cure diseases with a single treatment, companies could shrink their own market
Show less
Read more
Impact Snapshot
Event Time:
GS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GS alerts
High impacting Goldman Sachs Group, Inc. (The) news events
Weekly update
A roundup of the hottest topics
GS
News
- Yum (YUM) Q3 2025 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- World Insurance Associates Names John Newell as Chief Executive Officer; Founder Rich Eknoian New Executive Chairman [TheStreet.com]TheStreet.com
- What are today's CD interest rates? [Yahoo! Finance]Yahoo! Finance
- World Insurance Associates Names John Newell as Chief Executive Officer; Founder Rich Eknoian New Executive ChairmanPR Newswire
- Goldman Sachs and Houlihan Lokey top M&A advisers list in Q1 2026 [Yahoo! Finance]Yahoo! Finance
GS
Earnings
- 4/14/26 - Beat
GS
Sec Filings
- 4/21/26 - Form 424B2
- 4/21/26 - Form 424B2
- 4/21/26 - Form 424B2
- GS's page on the SEC website